Dr Jane Carr-Wilkinson Kieran O'Toole Angela Baker Julian Board Mike Cole et al. | High frequency of p53/MDM2/p14ARF pathway abnormalities in relapsed neuroblastoma | 2010 |
|
Professor John Lunec Julian Board Professor Andrew Pearson
| No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas [15] | 2005 |
|
Dr Tibor Nyari Professor Andrew Pearson Professor Deborah Tweddle Julian Board
| Large cell neuroblastoma: A distinct phenotype of neuroblastoma with aggressive clinical behavior | 2004 |
|
Professor Deborah Tweddle Julian Board Professor Andrew Pearson Professor John Lunec
| Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[131I]iodobenzylguanidine by neuroblastoma tumors | 2003 |
|
Dr Jane Carr-Wilkinson Julian Board Dr Katrina Wood Professor Andrew Pearson Professor John Lunec et al. | Selection for p53 mutant cells by chemotherapy in high-risk neuroblastoma | 2003 |
|
Dr Debbie Scott Julian Board Dr Xiaohong Lu Professor Andrew Pearson Dr Rebecca Kenyon et al. | The neuroblastoma amplified gene, NAG: Genomic structure and characterisation of the 7.3 kb transcript predominantly expressed in neuroblastoma | 2003 |
|
Professor John Lunec Julian Board Professor Andrew Pearson
| Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay | 2002 |
|